Corduroy Diagnostics, LLC
If you had a chance to save a life would you? CorduroyDx is seeking funds to commercialize a screening & diagnosis test for the early detection of liver cancer
Use funds to develop and validate blood, saliva, and urine based panel of molecular biomarkers to proof-of-concept for the screening, diagnosis, and staging of liver cancer while providing best-in-class sensitivity, specificity, and positive predictive value. We seek to generate revenues from sublicensing fees, milestone payments, & royalties to become an attractive acquisition target in a hot, growing Hep C/HCC market & generate a great return.